The International Common Mechanism for DNA Synthesis Screening
DNA synthesis is a service that is widely used in bioscience research and in laboratories around the world. It supports the growing bioeconomy and is critically important for a wide range of biotechnology advances. However, safeguards for DNA synthesis technology—to ensure that providers do not inadvertently sell the building blocks of dangerous pathogens to malicious actors—have not kept pace with growing global demand for this service and declining costs.
The international Common Mechanism will help DNA providers more effectively screen orders and customers to prevent DNA synthesis technology from being exploited. By providing this software, we seek to ensure that every DNA provider has access to DNA synthesis screening tools. This makes it easier for them to screen DNA sequences and customers efficiently and at lower cost, resulting in improved global biosecurity and biosafety. The Common Mechanism was developed and is supported by an international Technical Consortium of experts from across industry, academia, government, and civil society.
Learn more at www.IBBIS.bio